Volume 26, Issue 10
Research Article

An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies

L. Remontet

Corresponding Author

E-mail address: laurent.remontet@chu‐lyon.fr

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Laboratoire de Biostatistique‐Santé (UMR 5558), CNRS and Université Claude Bernard Lyon 1, Lyon, France

Service de Biostatistique, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 69495 Pierre‐Bénite Cedex, FranceSearch for more papers by this author
N. Bossard

E-mail address: nadine.bossard@chu‐lyon.fr

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Laboratoire de Biostatistique‐Santé (UMR 5558), CNRS and Université Claude Bernard Lyon 1, Lyon, France

Search for more papers by this author
A. Belot

E-mail address: aurelien.belot@chu‐lyon.fr

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Laboratoire de Biostatistique‐Santé (UMR 5558), CNRS and Université Claude Bernard Lyon 1, Lyon, France

Search for more papers by this author
J. Estève

E-mail address: jacques.esteve@chu‐lyon.fr

Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Laboratoire de Biostatistique‐Santé (UMR 5558), CNRS and Université Claude Bernard Lyon 1, Lyon, France

Search for more papers by this author
the French network of cancer registries FRANCIM

Head office: Réseau FRANCIM, Faculté de médecine, Toulouse, France

List of registries is given in the Appendix.

Search for more papers by this author
First published: 30 March 2007
Citations: 99

Abstract

Relative survival provides a measure of the proportion of patients dying from the disease under study without requiring the knowledge of the cause of death. We propose an overall strategy based on regression models to estimate the relative survival and model the effects of potential prognostic factors. The baseline hazard was modelled until 10 years follow‐up using parametric continuous functions. Six models including cubic regression splines were considered and the Akaike Information Criterion was used to select the final model. This approach yielded smooth and reliable estimates of mortality hazard and allowed us to deal with sparse data taking into account all the available information. Splines were also used to model simultaneously non‐linear effects of continuous covariates and time‐dependent hazard ratios. This led to a graphical representation of the hazard ratio that can be useful for clinical interpretation. Estimates of these models were obtained by likelihood maximization. We showed that these estimates could be also obtained using standard algorithms for Poisson regression. Copyright © 2006 John Wiley & Sons, Ltd.

Number of times cited according to CrossRef: 99

  • Nonlinear and time‐dependent effects of sparsely measured continuous time‐varying covariates in time‐to‐event analysis, Biometrical Journal, 10.1002/bimj.201900042, 62, 2, (492-515), (2020).
  • Prediction of cancer survival for cohorts of patients most recently diagnosed using multi-model inference, Statistical Methods in Medical Research, 10.1177/0962280220934501, 29, 12, (3605-3622), (2020).
  • Comparison of model-building strategies for excess hazard regression models in the context of cancer epidemiology, BMC Medical Research Methodology, 10.1186/s12874-019-0830-9, 19, 1, (2019).
  • Estimation of the adjusted cause‐specific cumulative probability using flexible regression models for the cause‐specific hazards, Statistics in Medicine, 10.1002/sim.8209, 38, 20, (3896-3910), (2019).
  • Assessing the time dependence of prognostic values of cytology and human papillomavirus testing in cervical cancer screening, International Journal of Cancer, 10.1002/ijc.31970, 144, 10, (2408-2418), (2019).
  • survPen: an R package for hazard and excess hazard modelling with multidimensional penalized splines, Journal of Open Source Software, 10.21105/joss.01434, 4, 40, (1434), (2019).
  • Trends in probabilities of death owing to cancer and owing to other causes in patients with colon cancer, European Journal of Gastroenterology & Hepatology, 10.1097/MEG.0000000000001387, 31, 5, (570-576), (2019).
  • On the use of flexible excess hazard regression models for describing long-term breast cancer survival: a case-study using population-based cancer registry data, BMC Cancer, 10.1186/s12885-019-5304-2, 19, 1, (2019).
  • Multi‐dimensional penalized hazard model with continuous covariates: applications for studying trends and social inequalities in cancer survival, Journal of the Royal Statistical Society: Series C (Applied Statistics), 10.1111/rssc.12368, 68, 5, (1233-1257), (2019).
  • HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort, BMJ Open, 10.1136/bmjopen-2018-024841, 9, 1, (e024841), (2019).
  • Correcting for misclassification and selection effects in estimating net survival in clinical trials, BMC Medical Research Methodology, 10.1186/s12874-019-0747-3, 19, 1, (2019).
  • On models for the estimation of the excess mortality hazard in case of insufficiently stratified life tables, Biostatistics, 10.1093/biostatistics/kxz017, (2019).
  • More accurate cancer-related excess mortality through correcting background mortality for extra variables, Statistical Methods in Medical Research, 10.1177/0962280218823234, (096228021882323), (2019).
  • A permutation test based on the restricted mean survival time for comparison of net survival distributions in non-proportional excess hazard settings, Statistical Methods in Medical Research, 10.1177/0962280219870217, (096228021987021), (2019).
  • Flexible Bayesian excess hazard models using low-rank thin plate splines, Statistical Methods in Medical Research, 10.1177/0962280219874094, (096228021987409), (2019).
  • Flexible and structured survival model for a simultaneous estimation of non-linear and non-proportional effects and complex interactions between continuous variables: Performance of this multidimensional penalized spline approach in net survival trend analysis, Statistical Methods in Medical Research, 10.1177/0962280218779408, 28, 8, (2368-2384), (2018).
  • Explained variation of excess hazard models, Statistics in Medicine, 10.1002/sim.7645, 37, 14, (2284-2300), (2018).
  • Further Development of Flexible Parametric Models for Survival Analysis, The Stata Journal: Promoting communications on statistics and Stata, 10.1177/1536867X0900900206, 9, 2, (265-290), (2018).
  • On a general structure for hazard-based regression models: An application to population-based cancer research, Statistical Methods in Medical Research, 10.1177/0962280218782293, (096228021878229), (2018).
  • Improving survival in end-stage renal disease: A case study, Statistical Methods in Medical Research, 10.1177/0962280218811357, (096228021881135), (2018).
  • Generalized survival models for correlated time‐to‐event data, Statistics in Medicine, 10.1002/sim.7451, 36, 29, (4743-4762), (2017).
  • Cancer Survival, International Encyclopedia of Public Health, 10.1016/B978-0-12-803678-5.00051-5, (406-421), (2017).
  • OBSOLETE: Cancer Survival, Reference Module in Biomedical Sciences, 10.1016/B978-0-12-801238-3.02745-8, (2017).
  • New insights into survival trend analyses in cancer population-based studies, European Journal of Cancer Prevention, 10.1097/CEJ.0000000000000301, 26, (S9-S15), (2017).
  • Cancer survival in Latin countries, European Journal of Cancer Prevention, 10.1097/CEJ.0000000000000318, 26, (S1-S2), (2017).
  • Performance of two formal tests based on martingales residuals to check the proportional hazard assumption and the functional form of the prognostic factors in flexible parametric excess hazard models, Biostatistics, 10.1093/biostatistics/kxw056, 18, 3, (505-520), (2017).
  • Restricted mean survival time over 15 years for patients starting renal replacement therapy, Nephrology Dialysis Transplantation, 10.1093/ndt/gfw386, (gfw386), (2017).
  • Validation of the alternating conditional estimation algorithm for estimation of flexible extensions of Cox's proportional hazards model with nonlinear constraints on the parameters, Biometrical Journal, 10.1002/bimj.201500035, 58, 6, (1445-1464), (2016).
  • A log‐rank‐type test to compare net survival distributions, Biometrics, 10.1111/biom.12477, 72, 3, (760-769), (2016).
  • A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non‐linear and non‐proportional effects of covariates, Statistics in Medicine, 10.1002/sim.6881, 35, 18, (3066-3084), (2016).
  • Adjusting for overdispersion in piecewise exponential regression models to estimate excess mortality rate in population-based research, BMC Medical Research Methodology, 10.1186/s12874-016-0234-z, 16, 1, (2016).
  • Challenges in the estimation of Net SURvival: The CENSUR working survival group, Revue d'Épidémiologie et de Santé Publique, 10.1016/j.respe.2016.05.005, 64, 5, (367-371), (2016).
  • Determinants of excess mortality following unprotected left main stem percutaneous coronary intervention, Heart, 10.1136/heartjnl-2015-308739, 102, 16, (1287-1295), (2016).
  • Flexible estimation of survival curves conditional on non‐linear and time‐dependent predictor effects, Statistics in Medicine, 10.1002/sim.6740, 35, 4, (553-565), (2015).
  • Prediction of the 10‐year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II, International Journal of Cancer, 10.1002/ijc.29705, 138, 2, (320-331), (2015).
  • Reply to Letter to the Editor by Remontet et al., Statistics in Medicine, 10.1002/sim.6606, 34, 25, (3378-3380), (2015).
  • Framework and optimisation procedure for flexible parametric survival models, Statistics in Medicine, 10.1002/sim.6489, 34, 25, (3376-3377), (2015).
  • Choosing the net survival method for cancer survival estimation, European Journal of Cancer, 10.1016/j.ejca.2013.09.019, 51, 9, (1123-1129), (2015).
  • Multi-state relative survival modelling of colorectal cancer progression and mortality, Cancer Epidemiology, 10.1016/j.canep.2015.03.005, 39, 3, (447-455), (2015).
  • Trends in cancer prognosis in a population-based cohort survey: Can recent advances in cancer therapy affect the prognosis?, Cancer Epidemiology, 10.1016/j.canep.2014.11.008, 39, 1, (97-103), (2015).
  • Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing–remitting multiple sclerosis, Journal of Clinical Epidemiology, 10.1016/j.jclinepi.2014.11.011, 68, 3, (307-316), (2015).
  • Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes, European Heart Journal - Quality of Care and Clinical Outcomes, 10.1093/ehjqcco/qcv011, 1, 2, (85-91), (2015).
  • Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5), The Lancet Haematology, 10.1016/S2352-3026(15)00155-6, 2, 11, (e481-e491), (2015).
  • Trends in excess mortality in follicular lymphoma at a population level, European Journal of Haematology, 10.1111/ejh.12403, 94, 2, (120-129), (2014).
  • Impact of the model‐building strategy on inference about nonlinear and time‐dependent covariate effects in survival analysis, Statistics in Medicine, 10.1002/sim.6178, 33, 19, (3318-3337), (2014).
  • STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative, Statistics in Medicine, 10.1002/sim.6265, 33, 30, (5413-5432), (2014).
  • A joint frailty model to estimate the recurrence process and the disease‐specific mortality process without needing the cause of death, Statistics in Medicine, 10.1002/sim.6140, 33, 18, (3147-3166), (2014).
  • A general framework for parametric survival analysis, Statistics in Medicine, 10.1002/sim.6300, 33, 30, (5280-5297), (2014).
  • A model combining excess and relative mortality for population‐based studies, Statistics in Medicine, 10.1002/sim.5919, 33, 2, (275-288), (2013).
  • Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study, British Journal of Cancer, 10.1038/bjc.2013.6, 108, 5, (1195-1208), (2013).
  • Impact of five modifiable lifestyle habits on the probability of cancer occurrence in a Japanese population-based cohort: Results from the JPHC study, Preventive Medicine, 10.1016/j.ypmed.2013.08.030, 57, 5, (685-689), (2013).
  • Improvement in survival of metastatic colorectal cancer: Are the benefits of clinical trials reproduced in population-based studies?, European Journal of Cancer, 10.1016/j.ejca.2013.04.001, 49, 13, (2919-2925), (2013).
  • Stage at diagnosis and colorectal cancer survival in six high-income countries: A population-based study of patients diagnosed during 2000–2007, Acta Oncologica, 10.3109/0284186X.2013.764008, 52, 5, (919-932), (2013).
  • Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: A study of five common cancers, Cancer Epidemiology, 10.1016/j.canep.2013.08.006, 37, 6, (857-863), (2013).
  • Profile of the Risk of Death After Septic Shock in the Present Era, Critical Care Medicine, 10.1097/CCM.0b013e31829a6e89, 41, 11, (2600-2609), (2013).
  • Description of an approach based on maximum likelihood to adjust an excess hazard model with a random effect, Cancer Epidemiology, 10.1016/j.canep.2013.04.001, 37, 4, (449-456), (2013).
  • Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007, Thorax, 10.1136/thoraxjnl-2012-202297, 68, 6, (551-564), (2013).
  • Cancer net survival on registry data: Use of the new unbiased Pohar‐Perme estimator and magnitude of the bias with the classical methods, International Journal of Cancer, 10.1002/ijc.27830, 132, 10, (2359-2369), (2012).
  • The impact of additional life‐table variables on excess mortality estimates, Statistics in Medicine, 10.1002/sim.5493, 31, 30, (4219-4230), (2012).
  • Estimating net survival: the importance of allowing for informative censoring, Statistics in Medicine, 10.1002/sim.4464, 31, 8, (775-786), (2012).
  • Effect of endocervical inflammation on days to conception in dairy cows, Journal of Dairy Science, 10.3168/jds.2011-4602, 95, 4, (1776-1783), (2012).
  • Comparison of methods for calculating relative survival in population-based studies, Cancer Epidemiology, 10.1016/j.canep.2011.05.010, 36, 1, (16-21), (2012).
  • Excess mortality and morbidity in patients surviving infective endocarditis, American Heart Journal, 10.1016/j.ahj.2012.04.003, 164, 1, (94-101), (2012).
  • Relative survival multistate Markov model, Statistics in Medicine, 10.1002/sim.4392, 31, 3, (269-286), (2011).
  • Flexible modeling of the effects of continuous prognostic factors in relative survival, Statistics in Medicine, 10.1002/sim.4208, 30, 12, (1351-1365), (2011).
  • Épidémiologie des cancers chez le sujet âgé, les résultats du réseau français des registres des cancers, Oncogériatrie, 10.1007/978-2-8178-0142-1, (11-18), (2011).
  • Competing risk models to estimate the excess mortality and the first recurrent-event hazards, BMC Medical Research Methodology, 10.1186/1471-2288-11-78, 11, 1, (2011).
  • Épidémiologie des cancers de la cavité buccale en France, Revue de Stomatologie et de Chirurgie Maxillo-faciale, 10.1016/j.stomax.2011.04.004, 112, 3, (164-171), (2011).
  • Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK – Authors' reply, The Lancet, 10.1016/S0140-6736(11)60457-1, 377, 9772, (1149-1150), (2011).
  • Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri, Cancer Epidemiology, 10.1016/j.canep.2010.10.008, 35, 3, (243-249), (2011).
  • Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study, Blood, 10.1182/blood-2011-01-330332, 118, 16, (4331-4337), (2011).
  • Relative survival after exposure to polychlorinated biphenyls and dioxins: A follow-up of Japanese patients affected in the Yusho incident, Science of The Total Environment, 10.1016/j.scitotenv.2011.03.007, 409, 12, (2361-2365), (2011).
  • Choosing the relative survival method for cancer survival estimation, European Journal of Cancer, 10.1016/j.ejca.2011.03.011, 47, 14, (2202-2210), (2011).
  • Clinical features and evolution of alveolar echinococcosis in France from 1982 to 2007: Results of a survey in 387 patients, Journal of Hepatology, 10.1016/j.jhep.2011.02.018, 55, 5, (1025-1033), (2011).
  • Flexible modeling improves assessment of prognostic value of C-reactive protein in advanced non-small cell lung cancer, British Journal of Cancer, 10.1038/sj.bjc.6605603, 102, 7, (1113-1122), (2010).
  • Flexible modeling of competing risks in survival analysis, Statistics in Medicine, 10.1002/sim.4005, 29, 23, (2453-2468), (2010).
  • Bootstrap‐based methods for estimating standard errors in Cox's regression analyses of clustered event times, Statistics in Medicine, 10.1002/sim.3807, 29, 7‐8, (915-923), (2010).
  • Estimating the crude probability of death due to cancer and other causes using relative survival models, Statistics in Medicine, 10.1002/sim.3762, 29, 7‐8, (885-895), (2010).
  • Descriptive epidemiology of thyroid cancer in France: Incidence, mortality and survival, Annales d'Endocrinologie, 10.1016/j.ando.2009.11.006, 71, 2, (95-101), (2010).
  • Changes in the risk of death from cancer up to five years after diagnosis in elderly patients: A study of five common cancers, International Journal of Cancer, 10.1002/ijc.25101, 127, 4, (924-931), (2009).
  • Confidence intervals for the first crossing point of two hazard functions, Lifetime Data Analysis, 10.1007/s10985-009-9132-6, 15, 4, (441-454), (2009).
  • Long‐term survival of intensive care and hospital patient cohorts compared with the general Australian population: a relative survival approach, Journal of Evaluation in Clinical Practice, 10.1111/j.1365-2753.2008.01030.x, 15, 3, (425-435), (2009).
  • Conditional relative survival of cancer patients and conditional probability of death, Cancer, 10.1002/cncr.24489, 115, 19, (4616-4624), (2009).
  • Modelling the trend of bovine spongiform encephalopathy prevalence in France: Use of restricted cubic spline regression in age–period–cohort models to estimate the efficiency of control measures, Preventive Veterinary Medicine, 10.1016/j.prevetmed.2009.04.001, 90, 1-2, (90-101), (2009).
  • Incidence and survival of gastric non-Hodgkin's lymphoma: A population-based study from the Association of the French Cancer Registries (FRANCIM), Acta Oncologica, 10.1080/02841860903032825, 48, 7, (977-983), (2009).
  • Exactitude of Relative Survival Compared with Cause-Specific Survival and Competing Risk Estimations Based on a Clinical Database of Patients with Colorectal Carcinoma, Diseases of the Colon & Rectum, 10.1007/DCR.0b013e3181a0dd71, 52, 7, (1264-1271), (2009).
  • Analysis of the effect of age on the prognosis of breast cancer, Breast Cancer Research and Treatment, 10.1007/s10549-008-0222-z, 117, 1, (121-129), (2008).
  • Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?, European Journal of Epidemiology, 10.1007/s10654-008-9226-6, 23, 4, (251-259), (2008).
  • The performance of multiple imputation for missing covariate data within the context of regression relative survival analysis, Statistics in Medicine, 10.1002/sim.3476, 27, 30, (6310-6331), (2008).
  • Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy, Statistics in Medicine, 10.1002/sim.3447, 27, 30, (6470-6488), (2008).
  • Avoiding infinite estimates of time‐dependent effects in small‐sample survival studies, Statistics in Medicine, 10.1002/sim.3418, 27, 30, (6455-6469), (2008).
  • Cancer Survival, International Encyclopedia of Public Health, 10.1016/B978-012373960-5.00267-7, (480-493), (2008).
  • Spécificités méthodologiques de l’analyse de survie des patients dialysés, Néphrologie & Thérapeutique, 10.1016/j.nephro.2008.02.008, 4, 7, (553-561), (2008).
  • Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM), European Journal of Cancer, 10.1016/j.ejca.2006.07.021, 43, 1, (149-160), (2007).
  • Flexible parametric models for relative survival, with application in coronary heart disease, Statistics in Medicine, 10.1002/sim.3064, 26, 30, (5486-5498), (2007).
  • Apports de l’épidémiologie descriptive, registres et cohortes, médecine/sciences, 10.1051/medsci/2007233s22, 23, (22-25), (2007).
  • Méthode d’estimation de la survie relative et modélisation de l’effet des facteurs pronostiques, Survie des patients atteints de cancer en France, 10.1007/978-2-287-39310-5, (11-15), (2007).
  • Survie des patients atteints de cancer en France: principaux résultats de la première étude du réseau des registres français des cancers (Francim)Survival of cancer patients in France: main results of the first large scale population-based “Francim study”, Oncologie, 10.1007/s10269-007-0721-2, 9, 7-8, (574-580), (2007).
  • Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA‐87 and LALA‐94 trials, Cancer, 10.1002/cncr.23097, 110, 12, (2747-2755), (2007).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.